Levi & Korsinsky, LLP Investigates SciClone Pharmaceuticals, Inc.
Levi & Korsinsky is investigating SciClone Pharmaceuticals, Inc. (“SciClone” or the “Company”) (NASDAQ:SCLN) for potentially violating state and federal securities laws by issuing false and misleading statements to its shareholders. Concerned shareholders should contact Joseph Levi at 877-363-5972 or by email at firstname.lastname@example.org for more information. All inquires will be kept in the strictest of confidence.
On August 9, 2010, SciClone revealed that the Securities and Exchange Commission has initiated a formal probe over certain business dealings in China. SciClone has also been contacted by the Department of Justice, which requested that the Company meet with them regarding its compliance with the Foreign Corrupt Practices Act (“FCPA”). On this news, shares of SciClone plunged 29% to $2.48. The FCPA prohibits a company from making illicit payments to foreign officials to obtain a business advantage.
If you purchased the common stock of SciClone and would like to discuss this action, or if you have any questions concerning your rights as a potential class member, please contact Joseph Levi either via email at email@example.com or by telephone at 877-363-5972, or visit http://www.zlk.com/sciclone-class-action.html.
Levi & Korsinsky has expertise in prosecuting investor securities
litigation and extensive experience in actions involving financial fraud
and represents investors throughout the nation, concentrating its
practice in securities and shareholder litigation.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV